Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Kazia and Dana-Farber to collaborate for Phase II GDC-0084 trial

About 10%-15% of women with stage IV breast cancer develop brain metastases. Credit: Kazia Therapeutics.

  • Cancer cells

Go Top